Why IMU is a multi multi bagger, page-10214

"...............biotech companies have a high probability of failing.............."

Statistically inarguable and many thanks for pointing that out shareman. Suggest a classic case of using statistics in isolation to build a case. Perhaps you could explain to us the "why" or "because" of that opening argument. For example they fail through lack of available funding because they were not able to convince the market of the merits of their project or because management was too focused on the science and not the timing or interest of its client requirements (solutions for problems that no longer are of interest to BP's) or, or, or ........ Now lets apply that to IMU. working capital (that's money in the bank) - not a problem, relevant product - tick, interest from the big boys - plenty, management has a clear plan to progress more than 1 pony in the race - tick.............. stats / averages are made up of outcomes both above and below the line. Personally confident IMU still is well above the line.

Wishing all - uprampers, downrampers, traders and holders and even those not holding, a happy, healthy and above all safe, festive season and year ahead. Thanks to those who take the time to think about their contributions to this forum and look forward to reading more in the coming year.